240 related articles for article (PubMed ID: 21052757)
1. Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies.
Arnan M; Gudiol C; Calatayud L; Liñares J; Dominguez MÁ; Batlle M; Ribera JM; Carratalà J; Gudiol F
Eur J Clin Microbiol Infect Dis; 2011 Mar; 30(3):355-60. PubMed ID: 21052757
[TBL] [Abstract][Full Text] [Related]
2. Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome.
Gudiol C; Calatayud L; Garcia-Vidal C; Lora-Tamayo J; Cisnal M; Duarte R; Arnan M; Marin M; Carratalà J; Gudiol F
J Antimicrob Chemother; 2010 Feb; 65(2):333-41. PubMed ID: 19959544
[TBL] [Abstract][Full Text] [Related]
3. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology.
Rodríguez-Baño J; López-Cerero L; Navarro MD; Díaz de Alba P; Pascual A
J Antimicrob Chemother; 2008 Nov; 62(5):1142-9. PubMed ID: 18641033
[TBL] [Abstract][Full Text] [Related]
4. 10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum β-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre.
Nicolas-Chanoine MH; Gruson C; Bialek-Davenet S; Bertrand X; Thomas-Jean F; Bert F; Moyat M; Meiller E; Marcon E; Danchin N; Noussair L; Moreau R; Leflon-Guibout V
J Antimicrob Chemother; 2013 Mar; 68(3):562-8. PubMed ID: 23143897
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.
Komatsu Y; Kasahara K; Inoue T; Lee ST; Muratani T; Yano H; Kirita T; Mikasa K
PLoS One; 2018; 13(8):e0202276. PubMed ID: 30157275
[TBL] [Abstract][Full Text] [Related]
6. A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies.
Vehreschild MJ; Hamprecht A; Peterson L; Schubert S; Häntschel M; Peter S; Schafhausen P; Rohde H; Lilienfeld-Toal MV; Bekeredjian-Ding I; Libam J; Hellmich M; Vehreschild JJ; Cornely OA; Seifert H
J Antimicrob Chemother; 2014 Dec; 69(12):3387-92. PubMed ID: 25103492
[TBL] [Abstract][Full Text] [Related]
7. Caretaker knowledge, attitudes, and practices (KAP) and carriage of extended-spectrum beta-lactamase-producing E. coli (ESBL-EC) in children in Quito, Ecuador.
Marusinec R; Kurowski KM; Amato HK; Saraiva-Garcia C; Loayza F; Salinas L; Trueba G; Graham JP
Antimicrob Resist Infect Control; 2021 Jan; 10(1):2. PubMed ID: 33407927
[TBL] [Abstract][Full Text] [Related]
8. Fecal ESBL Escherichia coli carriage as a risk factor for bacteremia in patients with hematological malignancies.
Cornejo-Juárez P; Suárez-Cuenca JA; Volkow-Fernández P; Silva-Sánchez J; Barrios-Camacho H; Nájera-León E; Velázquez-Acosta C; Vilar-Compte D
Support Care Cancer; 2016 Jan; 24(1):253-259. PubMed ID: 26014616
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer.
Ha YE; Kang CI; Cha MK; Park SY; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
Int J Antimicrob Agents; 2013 Nov; 42(5):403-9. PubMed ID: 24071027
[TBL] [Abstract][Full Text] [Related]
10. Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among humans in Java, Indonesia, in 2001-2002.
Severin JA; Lestari ES; Kloezen W; Lemmens-den Toom N; Mertaniasih NM; Kuntaman K; Purwanta M; Duerink DO; Hadi U; van Belkum A; Verbrugh HA; Goessens WH;
Trop Med Int Health; 2012 Apr; 17(4):455-61. PubMed ID: 22248076
[TBL] [Abstract][Full Text] [Related]
11. Infections caused by extended-spectrum β-lactamase-producing Enterobacterales after rectal colonization with ESBL-producing Escherichia coli or Klebsiella pneumoniae.
Denkel LA; Maechler F; Schwab F; Kola A; Weber A; Gastmeier P; Pfäfflin F; Weber S; Werner G; Pfeifer Y; Pietsch M; Leistner R
Clin Microbiol Infect; 2020 Aug; 26(8):1046-1051. PubMed ID: 31809805
[TBL] [Abstract][Full Text] [Related]
12. Fecal carriage rates of extended-spectrum β-lactamase-producing Escherichia coli among antibiotic naive healthy human volunteers.
Mathai D; Kumar VA; Paul B; Sugumar M; John KR; Manoharan A; Kesavan LM
Microb Drug Resist; 2015 Feb; 21(1):59-64. PubMed ID: 25127253
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year study.
Denis B; Lafaurie M; Donay JL; Fontaine JP; Oksenhendler E; Raffoux E; Hennequin C; Allez M; Socie G; Maziers N; Porcher R; Molina JM
Int J Infect Dis; 2015 Oct; 39():1-6. PubMed ID: 26189774
[TBL] [Abstract][Full Text] [Related]
14. Emergence and Comparative Genomics Analysis of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Carrying
Feng C; Wen P; Xu H; Chi X; Li S; Yu X; Lin X; Wu S; Zheng B
mSphere; 2019 Nov; 4(6):. PubMed ID: 31748247
[TBL] [Abstract][Full Text] [Related]
15. Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia.
Matsumura Y; Nagao M; Iguchi M; Yagi T; Komori T; Fujita N; Yamamoto M; Matsushima A; Takakura S; Ichiyama S
Clin Microbiol Infect; 2013 Feb; 19(2):161-8. PubMed ID: 22332968
[TBL] [Abstract][Full Text] [Related]
16. Transmission dynamics of extended-spectrum β-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting.
Hilty M; Betsch BY; Bögli-Stuber K; Heiniger N; Stadler M; Küffer M; Kronenberg A; Rohrer C; Aebi S; Endimiani A; Droz S; Mühlemann K
Clin Infect Dis; 2012 Oct; 55(7):967-75. PubMed ID: 22718774
[TBL] [Abstract][Full Text] [Related]
17. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.
Trecarichi EM; Tumbarello M; Spanu T; Caira M; Fianchi L; Chiusolo P; Fadda G; Leone G; Cauda R; Pagano L
J Infect; 2009 Apr; 58(4):299-307. PubMed ID: 19272650
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of rectal carriage of extended-spectrum beta-lactamase-producing Escherichia coli among elderly people in community settings in China.
Tian SF; Chen BY; Chu YZ; Wang S
Can J Microbiol; 2008 Sep; 54(9):781-5. PubMed ID: 18772941
[TBL] [Abstract][Full Text] [Related]
19. [Investigation of beta-lactamase genes and clonal relationship among the extended-spectrum beta-lactamase producing nosocomial Escherichia coli isolates].
Görgeç S; Kuzucu Ç; Otlu B; Yetkin F; Ersoy Y
Mikrobiyol Bul; 2015 Jan; 49(1):15-25. PubMed ID: 25706727
[TBL] [Abstract][Full Text] [Related]
20. Prolonged colonisation with Escherichia coli O25:ST131 versus other extended-spectrum beta-lactamase-producing E. coli in a long-term care facility with high endemic level of rectal colonisation, the Netherlands, 2013 to 2014.
Overdevest I; Haverkate M; Veenemans J; Hendriks Y; Verhulst C; Mulders A; Couprie W; Bootsma M; Johnson J; Kluytmans J
Euro Surveill; 2016 Oct; 21(42):. PubMed ID: 27784530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]